Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab

Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab THE CUTTING EDGE: CHALLENGES IN MEDICAL AND SURGICAL THERAPIES SECTION EDITOR: EDWARD W. COWEN, MD, MHSc; ASSISTANT SECTION EDITORS: MURAD ALAM, MD; RUTH ANN VLEUGELS, MD Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab Aieska De Souza, MD; Trisha Ali-Shaw, BA; Bruce E. Strober, MD, PhD; Andrew G. Franks Jr, MD; Department of Dermatology (Drs De Souza, Strober, and Franks and Ms Ali-Shaw) and Division of Rheumatology, Department of Medicine (Dr Franks), New York University, New York REPORT OF A CASE THERAPEUTIC CHALLENGE A 58-year-old woman presented with a history of sub- Patients with cutaneous lupus erythematosus experi- 1,2 acute cutaneous lupus erythematosus (SCLE) for the past ence significant morbidity. Current therapeutic 6 years, associated with photosensitivity, arthralgia, and options benefit the majority of patients; however, up fatigue. There was no evidence of systemic lupus ery- to 15% of cases are refractory to these conventional 3,4 thematosus (SLE) or any history of exposure to drugs therapies. General treatment recommendations known to induce SCLE. Previous treatments included hy- involve avoidance of direct sunlight, smoking cessa- droxychloroquine sulfate, dapsone, prednisone, azathio- tion, and the discontinuation of any drugs suspected 1-4 prine, mycophenolate mofetil, topical corticosteroids, and of inducing or exacerbating SCLE. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab

Loading next page...
 
/lp/american-medical-association/successful-treatment-of-subacute-lupus-erythematosus-with-ustekinumab-jjAt9M8vor
Publisher
American Medical Association
Copyright
Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/archdermatol.2011.185
pmid
21844448
Publisher site
See Article on Publisher Site

Abstract

THE CUTTING EDGE: CHALLENGES IN MEDICAL AND SURGICAL THERAPIES SECTION EDITOR: EDWARD W. COWEN, MD, MHSc; ASSISTANT SECTION EDITORS: MURAD ALAM, MD; RUTH ANN VLEUGELS, MD Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab Aieska De Souza, MD; Trisha Ali-Shaw, BA; Bruce E. Strober, MD, PhD; Andrew G. Franks Jr, MD; Department of Dermatology (Drs De Souza, Strober, and Franks and Ms Ali-Shaw) and Division of Rheumatology, Department of Medicine (Dr Franks), New York University, New York REPORT OF A CASE THERAPEUTIC CHALLENGE A 58-year-old woman presented with a history of sub- Patients with cutaneous lupus erythematosus experi- 1,2 acute cutaneous lupus erythematosus (SCLE) for the past ence significant morbidity. Current therapeutic 6 years, associated with photosensitivity, arthralgia, and options benefit the majority of patients; however, up fatigue. There was no evidence of systemic lupus ery- to 15% of cases are refractory to these conventional 3,4 thematosus (SLE) or any history of exposure to drugs therapies. General treatment recommendations known to induce SCLE. Previous treatments included hy- involve avoidance of direct sunlight, smoking cessa- droxychloroquine sulfate, dapsone, prednisone, azathio- tion, and the discontinuation of any drugs suspected 1-4 prine, mycophenolate mofetil, topical corticosteroids, and of inducing or exacerbating SCLE.

Journal

JAMA DermatologyAmerican Medical Association

Published: Aug 1, 2011

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month